Medical University of Vienna

Surgical Research
Waehringer Guertel 18-20
1090 Vienna / Austria / Europe
Phone: +43 1 40400 6848 (lab)
Daniela.Kandioler@meduniwien.ac.at

• Overall, fifty percent of patients currently do not benefit from standard cancer treatment.
• Markers, identifying patients who will benefit from a certain treatment are urgently needed.
• The p53 gene plays a crucial role in the way a tumour responds to chemotherapy.
• The major task of our research group is to set out for the clinical application of p53 as predictive marker in cancer therapy.